Mind.Px™ Psoriasis Biologics Test
Psoriasis (treatment selection)
ApprovedActive
Key Facts
About Mindera
Mindera Health, founded in 2019 and based in San Diego, is pioneering a novel diagnostic platform in dermatology. Its core technology, the Mind.Px™ patch, painlessly extracts RNA from the skin for transcriptomic analysis, aiming to replace subjective visual exams and invasive biopsies. The company is building the SkinAtlas™ dataset to power AI-driven analytics for skin diseases, with a validated initial application in guiding biologic selection for psoriasis, as demonstrated in a recent prospective clinical trial. Mindera positions its platform as a foundational tool for digital skin analytics across healthcare and consumer sectors.
View full company profile